Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 3 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer EMA Recommends Extension of Indications for Selpercatinib MOST POPULAR Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug April 23, 2018 Stopping neuropathy: One of chemotherapy’s most challenging side effects May 22, 2023 Adding Blinatumomab to Consolidation Chemotherapy Improves OS in Adult Patients in... August 12, 2024 FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory B-Cell Precursor Acute... October 7, 2021 Load more HOT NEWS NCI Launches New Resource for Specimens and Data from Cancer Clinical... Merging the Histologic and Molecular Data Into an Integrated Score Significantly... Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reported... EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma
